Literature DB >> 16299346

Neutralization of tumor necrosis factor alpha suppresses antigen-specific type 1 cytokine responses and reverses the inhibition of mycobacterial survival in cocultures of immune guinea pig T lymphocytes and infected macrophages.

Hyosun Cho1, David N McMurray.   

Abstract

Neutralization of tumor necrosis factor alpha (TNF-alpha) significantly down-regulated antigen-induced lymphoproliferation and the expression of interleukin-12 p40 and gamma interferon mRNA and enhanced the viability of intracellular attenuated and virulent mycobacteria in cocultures of immune T cells and macrophages obtained from Mycobacterium bovis BCG-vaccinated guinea pigs. This suggests the crucial role of TNF-alpha in the activation of a type 1 T-cell response against Mycobacterium tuberculosis infection.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16299346      PMCID: PMC1307076          DOI: 10.1128/IAI.73.12.8437-8441.2005

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  27 in total

Review 1.  Immunology of tuberculosis.

Authors:  J L Flynn; J Chan
Journal:  Annu Rev Immunol       Date:  2001       Impact factor: 28.527

2.  Interleukin-12 as successful adjuvant in tuberculosis treatment.

Authors:  U Greinert; M Ernst; M Schlaak; P Entzian
Journal:  Eur Respir J       Date:  2001-05       Impact factor: 16.671

3.  Induction of interleukin-12 and gamma interferon requires tumor necrosis factor alpha for protective T1-cell-mediated immunity to pulmonary Cryptococcus neoformans infection.

Authors:  Amy C Herring; John Lee; Roderick A McDonald; Galen B Toews; Gary B Huffnagle
Journal:  Infect Immun       Date:  2002-06       Impact factor: 3.441

4.  Induction of TNF in human alveolar macrophages as a potential evasion mechanism of virulent Mycobacterium tuberculosis.

Authors:  Matthias Engele; Elmar Stössel; Kirstin Castiglione; Nives Schwerdtner; Manfred Wagner; Pal Bölcskei; Martin Röllinghoff; Steffen Stenger
Journal:  J Immunol       Date:  2002-02-01       Impact factor: 5.422

5.  Recombinant guinea pig tumor necrosis factor alpha stimulates the expression of interleukin-12 and the inhibition of Mycobacterium tuberculosis growth in macrophages.

Authors:  Hyosun Cho; Todd M Lasco; Shannon Sedberry Allen; Teizo Yoshimura; David N McMurray
Journal:  Infect Immun       Date:  2005-03       Impact factor: 3.441

Review 6.  Immunology of tuberculosis and implications in vaccine development.

Authors:  JoAnne L Flynn
Journal:  Tuberculosis (Edinb)       Date:  2004       Impact factor: 3.131

7.  Coordinate cytokine gene expression in vivo following induction of tuberculous pleurisy in guinea pigs.

Authors:  Shannon Sedberry Allen; David N McMurray
Journal:  Infect Immun       Date:  2003-08       Impact factor: 3.441

8.  Effect of Mycobacterium bovis BCG vaccination on Mycobacterium-specific cellular proliferation and tumor necrosis factor alpha production from distinct guinea pig leukocyte populations.

Authors:  Todd M Lasco; Toshiko Yamamoto; Teizo Yoshimura; Shannon Sedberry Allen; Lynne Cassone; David N McMurray
Journal:  Infect Immun       Date:  2003-12       Impact factor: 3.441

Review 9.  Human immunity to M. tuberculosis: T cell subsets and antigen processing.

Authors:  W H Boom; David H Canaday; Scott A Fulton; Adam J Gehring; Roxana E Rojas; Marta Torres
Journal:  Tuberculosis (Edinb)       Date:  2003       Impact factor: 3.131

Review 10.  Interleukin-12 and the regulation of innate resistance and adaptive immunity.

Authors:  Giorgio Trinchieri
Journal:  Nat Rev Immunol       Date:  2003-02       Impact factor: 53.106

View more
  8 in total

Review 1.  Latent tuberculosis infection: myths, models, and molecular mechanisms.

Authors:  Noton K Dutta; Petros C Karakousis
Journal:  Microbiol Mol Biol Rev       Date:  2014-09       Impact factor: 11.056

2.  The in vivo immunomodulatory effect of recombinant tumour necrosis factor-alpha in guinea pigs vaccinated with Mycobacterium bovis bacille Calmette-Guérin.

Authors:  J C Kramp; D N McMurray; C Formichella; A Jeevan
Journal:  Clin Exp Immunol       Date:  2011-05-05       Impact factor: 4.330

3.  Guinea pig neutrophils infected with Mycobacterium tuberculosis produce cytokines which activate alveolar macrophages in noncontact cultures.

Authors:  Kirti V Sawant; David N McMurray
Journal:  Infect Immun       Date:  2007-02-05       Impact factor: 3.441

4.  Neutralization of TNFalpha alters inflammation in guinea pig tuberculous pleuritis.

Authors:  Lan H Ly; Amminikutty Jeevan; David N McMurray
Journal:  Microbes Infect       Date:  2009-04-21       Impact factor: 2.700

5.  Lung macrophages from bacille Calmette-Guérin-vaccinated guinea pigs suppress T cell proliferation but restrict intracellular growth of M. tuberculosis after recombinant guinea pig interferon-gamma activation.

Authors:  A Jeevan; K Majorov; K Sawant; H Cho; D N McMurray
Journal:  Clin Exp Immunol       Date:  2007-06-12       Impact factor: 4.330

Review 6.  The guinea pig as a model of infectious diseases.

Authors:  Danielle J Padilla-Carlin; David N McMurray; Anthony J Hickey
Journal:  Comp Med       Date:  2008-08       Impact factor: 0.982

Review 7.  Host-directed therapy targeting the Mycobacterium tuberculosis granuloma: a review.

Authors:  Dilara Kiran; Brendan K Podell; Mark Chambers; Randall J Basaraba
Journal:  Semin Immunopathol       Date:  2015-10-28       Impact factor: 9.623

8.  Haemophilus parasuis subunit vaccines based on native proteins with affinity to porcine transferrin prevent the expression of proinflammatory chemokines and cytokines in pigs.

Authors:  R Frandoloso; S Martínez-Martínez; E F Rodríguez-Ferri; S Yubero; D Rodríguez-Lázaro; M Hernández; C B Gutiérrez-Martín
Journal:  Clin Dev Immunol       Date:  2013-11-21
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.